<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0630">
 <label>126</label>
 <mixed-citation publication-type="other" id="or0350">CanSinoBIO's Investigational Vaccine Against COVID-19 Approved for Phase 1 Clinical Trial in China-CanSino Biologics Inc, (n.d). http://www.cansinotech.com/homes/article/show/56/153.html (accessed June 18, 2020).</mixed-citation>
</ref>
